DUBLIN, Feb. 26, 2021 /PRNewswire/ -- The "Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
The global artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026.
Market growth is largely driven by the growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth.
However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of this market during the forecast period.
Human cornea segment accounted for the largest share of artificial cornea and corneal implant market in 2020.
On the basis of type, the artificial cornea and corneal implants market is segmented into the human cornea and artificial cornea. In 2020, the human cornea segment accounted for the largest share of the artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising awareness regarding corneal transplantation and eye tissue donations, especially in developing economies.
Penetrating keratoplasty segment accounted for the largest share of the artificial cornea and corneal implant market in 2020.
On the basis of transplant type, the artificial cornea and corneal implants market is segmented into penetrating keratoplasty, endothelial keratoplasty, and other transplants (including anterior lamellar keratoplasty (ALK) and keratoprosthesis). In 2020, the penetrating keratoplasty segment accounted for the largest share of the global artificial cornea and corneal implants market. The large share of this segment can be attributed to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.
North America accounted for the largest share of the artificial cornea and corneal implant market in 2020.
Geographically, the artificial cornea and corneal implant market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. In 2020, North America accounted for the largest share of the global artificial cornea and corneal implants market. The market is well-established in North America, with the US dominating the market in this region. The large share of North America is mainly attributed to the established healthcare infrastructure, higher adoption of sophisticated healthcare technologies, higher budget among end users of ophthalmic devices, and a large number of manufacturers for corneal implants in the region.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Artificial Cornea and Corneal Implants Market Overview
4.2 Asia-Pacific: Artificial Cornea and Corneal Implants Market, by Type and End-user (2020)
4.3 Artificial Cornea and Corneal Implants Market, by Region, 2021-2026
4.4 Artificial Cornea and Corneal Implants Market: Developing Vs. Developed Markets
4.5 Artificial Cornea and Corneal Implants Market: Geographic Growth Opportunities
5 Market Overview
5.2 Market Dynamics
5.2.1 Market Drivers
126.96.36.199 Rapid Growth in the Geriatric Population
188.8.131.52 Rising Prevalence of Eye Diseases
184.108.40.206.1 Corneal Blindness
220.127.116.11.4 Obesity and Diabetes
18.104.22.168 Increasing Government Initiatives to Control Visual Impairment
22.214.171.124 High Cost of Ophthalmology Devices and Surgical Procedures
126.96.36.199 Shortage of Corneal Donors
188.8.131.52 Untapped Potential of Emerging Markets
184.108.40.206 Lack of Awareness and Low Access to Eye Care in Low-Income Economies
220.127.116.11 Shortage of Ophthalmologists
6 Industry Insights
6.2 Industry Trends
6.2.1 3D-Printed Human Corneas
6.2.2 Oct Angiography Devices
6.2.3 Advances in Refractive Surgery
6.3 Impact of COVID-19 on the Artificial Cornea and Corneal Implants Market
6.4 Value Chain Analysis
6.6 Regulatory Analysis
6.6.1 North America
7 Artificial Cornea and Corneal Implants Market, by Type
7.2 Human Cornea
7.2.1 Increasing Prevalence of Corneal Blindness to Drive Market Growth
7.3 Artificial Cornea
7.3.1 Scarcity of Human Eye Donors Has Propelled Market Growth
8 Artificial Cornea and Corneal Implants Market, by Transplant Type
8.2 Penetrating Keratoplasty
8.2.1 Pk Enables the Ability to Treat Keratitis and Injury of the Eyeball
8.3 Endothelial Keratoplasty
8.3.1 Advantages Such as Faster Visual Recovery and Less Prone to Injury are Supporting the Growth of this Segment
8.4 Other Transplants
9 Artificial Cornea and Corneal Implants Market, by Disease Indication
9.2 Fuchs' Dystrophy
9.2.1 Rising Prevalence of Fuchs' Dystrophy is the Key Factor Driving Market Growth
9.3 Fungal Keratitis
9.3.1 Large Patient Population Suffering from Fungus Keratitis to Drive Market Growth
9.4.1 Increasing Research on Keratoconus Treatment to Support Market Growth
9.5 Other Diseases
10 Artificial Cornea and Corneal Implants Market, by End-user
10.2 Impact of COVID-19 on the End-User Market
10.3.1 Large Patient Pool and High Purchasing Power of Hospitals are the Key Factors Driving Market Growth
10.4 Specialty Clinics & Ambulatory Surgery Centers
10.4.1 Cost-Effectiveness of Ambulatory Care Has Resulted in Growing End-User Interest Towards Ascs
11 Artificial Cornea and Corneal Implants Market, by Region
11.2 North America
11.5 Latin America
11.6 Middle East & Africa
12 Competitive Landscape
12.2 Artificial Cornea Market Ranking
12.3 Human Cornea Market Ranking
12.4 Product Benchmarking
12.5 Competitive Situations & Trends
12.5.1 Product Launches & Approvals
12.5.4 Other Developments
13 Company Evaluation Matrix Definition & Methodology and Company Profiles
13.1 Competitive Leadership Mapping
13.1.2 Emerging Leaders
13.1.3 Pervasive Companies
13.1.4 Emerging Companies
13.2 Competitive Leadership Mapping for Startups
13.2.1 Progressive Companies
13.2.2 Dynamic Companies
13.2.3 Starting Blocks
13.2.4 Responsive Companies
13.3 Company Profiles
13.3.1 Ajl Ophthalmic S.A.
13.3.2 Corneagen, Inc.
13.3.3 Addition Technology, Inc.
13.3.4 Linkocare Life Sciences Ab
13.3.5 Presbia plc
13.3.8 Cornea Biosciences, Inc.
13.3.9 Dioptex Medizinprodukte Forschungs-, Entwicklungs- Und Vertriebs GmbH (Dioptex GmbH)
13.3.10 Eyeyon Medical
13.3.11 Massachusetts Eye and Ear
13.3.12 Florida Lions Eye Bank
13.3.14 Advancing Sight Network
13.3.15 San Diego Eye Bank
13.3.16 L V Prasad Eye Institute
13.3.17 New Mexico Lions Eye Bank
13.3.18 San Antonio Eye Bank
13.3.19 Kansas Eye Bank & Cornea Research Center
13.3.20 Rocky Mountain Lions Eye Bank
13.3.21 Corneat Vision
13.3.22 Keramed, Inc.
14.1 Insights of Industry Experts
14.2 Discussion Guide
For more information about this report visit https://www.researchandmarkets.com/r/yujadp
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
These press releases may also interest you